𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical significance of MMP-2 and MMP-9 in patients with oral cancer

✍ Scribed by Beena P. Patel; Shakuntala V. Shah; Shilin N. Shukla; Pankaj M. Shah; Prabhudas S. Patel

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
473 KB
Volume
29
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background.

Factors that represent the potential for invasion and metastasis, such as matrix metalloproteinases (MMPs), could predict prognosis of cancer. Therefore, the authors studied plasma and tissue levels of MMP‐2 and MMP‐9 in oral cancer, the leading malignancy in India.

Methods.

Enzyme‐linked immunosorbent assay and gelatin zymography were used for the MMP analysis from plasma and tissue samples, respectively.

Results.

Latent, active, and total forms and activation ratio of MMP‐2 and MMP‐9 were significantly elevated in malignant tissues as compared with adjacent normal tissues. Activation of MMP‐2 was higher than MMP‐9 in malignant tissues. Activation ratio was significantly higher in malignant tissues of the patients with lymph node metastasis as compared with those without lymph node metastasis (p = .005). Plasma MMP‐9 levels were significantly lower in responders as compared with pretreatment levels (p = .002).

Conclusion.

The data indicate that MMP‐2 and MMP‐9 can be useful to identify metastatic phenotype as well as for treatment monitoring in oral cancer. Β© 2007 Wiley Periodicals, Inc. Head Neck, 2007

πŸ“œ SIMILAR VOLUMES

Role of MT-MMPs and MMP-2 in pancreatic
Role of MT-MMPs and MMP-2 in pancreatic cancer progression
✍ Volker Ellenrieder; Burkhard Alber; Ulrike Lacher; Sandra F. Hendler; Andre Menk πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 277 KB πŸ‘ 2 views

Activation of matrix metalloproteinase-2 (MMP-2) by the membrane-type matrix metalloproteinases (MT-MMPs) has been associated with tumor progression. In the present study, we examined the role of MMP-2 and its activators MT1-MMP, MT2-MMP and MT3-MMP in pancreatic tumor cell invasion and the developm

Use of plasma MMP-2 and MMP-9 levels as
Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients
✍ Matthew G. Tutton; Mark L. George; Suzanne A. Eccles; Sarah Burton; R. Ian Swift πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 203 KB πŸ‘ 1 views

Matrix metalloproteinases, and notably the gelatinases MMP-2 and MMP-9, have important roles in tumour invasion, metastasis and angiogenesis. Our study investigates the distribution of MMP-2 and MMP-9 in colorectal cancer, the correlation with plasma levels, changes following surgical resection and

Analysis of MT1-MMP and MMP2 expression
Analysis of MT1-MMP and MMP2 expression in human gastric cancers
✍ Masaki Mori; Koshi Mimori; Takeshi Shiraishi; Tatsuo Fujie; Kinya Baba; Hiroki K πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 217 KB πŸ‘ 2 views

## Membrane -type 1 matrix metalloproteinase (MT1-MMP) is a presumed activator of MMP2, which is one of the major proteinases in tumor cell invasion. In this study, we determined the clinico-pathologic significance of MT1-MMP expression in 68 human gastric carcinomas. The tumor-normal ratio (T/N r

Vascular endothelial growth factor expre
Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas
✍ Carine Munaut; AgnΓ¨s NoΓ«l; Olivier Hougrand; Jean-Michel Foidart; Jacques Bonive πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 340 KB πŸ‘ 1 views

Vascular endothelial growth factor (VEGF) is the major endothelial mitogen in central nervous system neoplasms and it is expressed in 64-95% of glioblastomas (GBMs). Tumour cells are the main source of VEGF in GBMs whereas VEGF receptors (VEGFR-1, its soluble form sVEGFR-1, VEGFR-2 and neuropilin-1)